Interleukin 4 treatment of psoriasis: are pleiotropic cytokines suitable therapies for autoimmune diseases?

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.12, 2003-12, pp. : 613-616

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biologic therapies in autoimmune diseases

By Penn Henry

Clinical Medicine, Vol. 6, Iss. 1, 2006-01 ,pp. : 105-108

Royal College Of Physicians

Access to resources Recommend Favorite

Biological Therapies of Autoimmune Diseases

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. : 41-46

Bentham Science Publishers

Access to resources Recommend Favorite

Highly Selective Phosphodiesterase 4 Inhibitors for the Treatment of Allergic Skin Diseases and Psoriasis

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 1, 2007-03 ,pp. : 17-26

Bentham Science Publishers

Access to resources Recommend Favorite

Th22 and related cytokines in inflammatory and autoimmune diseases

By Tian Tian Yu Shuang Ma Daoxin

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 2, 2013-02 ,pp. : 113-125

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF- Antibody Therapies in Autoimmune Diseases

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 16, 2006-08 ,pp. : 1707-1714

Bentham Science Publishers

Access to resources Recommend Favorite